Northeast Pharmaceutical Group Co Ltd (000597) — Free Cash Flow Generation Index
Northeast Pharmaceutical Group Co Ltd (000597) has a Free Cash Flow Generation Index of 0.96x as of September 2025. Free cash flow of CN¥262.61 Million represents 1% of operating cash flow (CN¥274.09 Million). Explore 000597 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Northeast Pharmaceutical Group Co Ltd Free Cash Flow Generation Index (1999–2025)
Historical FCF Generation Index trend for Northeast Pharmaceutical Group Co Ltd across 23 annual periods. For the full cash flow conversion analysis, see Northeast Pharmaceutical Group Co Ltd operating cash flow efficiency.
Annual Free Cash Flow Generation for Northeast Pharmaceutical Group Co Ltd (1999–2025)
Year-by-year Free Cash Flow Generation Index for Northeast Pharmaceutical Group Co Ltd. Check Northeast Pharmaceutical Group Co Ltd (000597) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.91x | CN¥1.01 Billion | CN¥1.11 Billion | CN¥97.78 Million | ▲ +15.4% |
| 2024 | 0.79x | CN¥599.34 Million | CN¥758.76 Million | CN¥159.43 Million | ▲ +31.9% |
| 2023 | 0.60x | CN¥351.32 Million | CN¥586.75 Million | CN¥235.43 Million | ▼ -23.2% |
| 2022 | 0.78x | CN¥864.44 Million | CN¥1.11 Billion | CN¥244.13 Million | ▼ -7.1% |
| 2021 | 0.84x | CN¥626.70 Million | CN¥746.51 Million | CN¥119.81 Million | ▲ +181.0% |
| 2020 | 0.30x | CN¥170.54 Million | CN¥570.92 Million | CN¥400.38 Million | ▼ -14.7% |
| 2019 | 0.35x | CN¥123.43 Million | CN¥352.60 Million | CN¥229.17 Million | ▲ +135.6% |
| 2018 | -0.98x | CN¥-280.65 Million | CN¥285.09 Million | CN¥565.74 Million | ▼ -282.4% |
| 2016 | 0.54x | CN¥207.51 Million | CN¥384.51 Million | CN¥177.01 Million | ▲ +121.8% |
| 2015 | -2.47x | CN¥-246.34 Million | CN¥99.70 Million | CN¥346.04 Million | ▲ +76.1% |
| 2014 | -10.33x | CN¥-485.28 Million | CN¥46.99 Million | CN¥532.27 Million | ▼ -857.9% |
| 2012 | -1.08x | CN¥-92.81 Million | CN¥86.09 Million | CN¥178.90 Million | ▼ -26.6% |
| 2010 | -0.85x | CN¥-217.97 Million | CN¥255.96 Million | CN¥473.93 Million | ▼ -112.4% |
| 2009 | -0.40x | CN¥-246.88 Million | CN¥615.91 Million | CN¥862.78 Million | ▼ -181.3% |
| 2008 | 0.49x | CN¥349.76 Million | CN¥709.03 Million | CN¥359.27 Million | ▼ -11.6% |
| 2007 | 0.56x | CN¥110.78 Million | CN¥198.56 Million | CN¥87.78 Million | ▲ +702.3% |
| 2005 | 0.07x | CN¥7.75 Million | CN¥111.40 Million | CN¥103.66 Million | ▼ -90.2% |
| 2004 | 0.71x | CN¥149.92 Million | CN¥211.06 Million | CN¥61.14 Million | ▲ +14.6% |
| 2003 | 0.62x | CN¥142.63 Million | CN¥230.08 Million | CN¥87.46 Million | ▼ -18.2% |
| 2002 | 0.76x | CN¥119.34 Million | CN¥157.41 Million | CN¥38.07 Million | ▲ +85.2% |
| 2001 | 0.41x | CN¥32.27 Million | CN¥78.84 Million | CN¥46.57 Million | ▼ -38.2% |
| 2000 | 0.66x | CN¥23.94 Million | CN¥36.13 Million | CN¥12.18 Million | ▼ -19.9% |
| 1999 | 0.83x | CN¥45.22 Million | CN¥54.62 Million | CN¥9.41 Million | — |